Patients with NF2 -related schwannomatosis ( NF2 -SWN) present with hallmark bilateral vestibular schwannomas, but also schwannomas on other cranial, spinal, and peripheral nerves, as well as meningiomas and ependymomas, caused by germline mutations in the tumor suppressor gene NF2 ....
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change for clinical practice; this is preclinical (mouse model) research that may eventually inform drug targets for NF2-related schwannomatosis, but human translation is not yet established.
Identifying Merlin restoration as a potential therapeutic strategy for vestibular schwannoma progression could open new treatment avenues for a condition that currently has limited non-surgical options.
- 01Restoring Merlin protein halted schwannoma tumor progression in a genetically engineered mouse model.
- 02NF2-related schwannomatosis causes bilateral vestibular schwannomas and significant hearing loss.
- 03This is a preprint study; findings have not yet undergone full peer review.
- 04Results are preclinical only — human efficacy and safety remain untested.
- 05Merlin is the protein product of the NF2 tumor suppressor gene.
Merlin protein restoration prevents schwannoma progression in a genetically engineered mouse model of NF2-related schwannomatosis.
studypartially supported- PMID
- 42779794
- DOI
- 10.64898/2026.09.12.751200.
- Publication type
- research_article
- Evidence level
- na
- Population
- Genetically engineered mouse model of NF2-related schwannomatosis
- Intervention
- Merlin protein restoration
- Comparator
- No Merlin restoration (control mice)
Primary outcomes
Schwannoma tumor progression